Pfizer's New COVID-19 Booster Targets Omicron Variant, Offers Extra Protection for Kids
The FDA has authorized Pfizer-BioNTech's bivalent COVID-19 vaccine for children aged 6 months to 4 years. The booster showed greater effectiveness against COVID-19 hospitalization.
Source: parentherald.com